Infarct size and recurrence of ventricular arrhythmias after defibrillator implantation

European Journal of Nuclear Medicine

Volumn 27, Issue 7, 2000, Pages 807-815

  De Sutter, Johan ^a   Tavernier, Rene ^a   Van de Wiele, Christophe ^b   Kazmierckzak, Jaroslaw ^a   De Buyzere, Marc ^a   Jordaens, Luc ^b   Clement, Denis L ^a   Dierckx, Rudi A ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arrhythmias; Defibrillator; Imaging; Infarct size; Tomography

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SOTALOL; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART SCINTISCANNING; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MALE; RECURRENT DISEASE; RISK ASSESSMENT; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; AGED; CORONARY DISEASE; DEFIBRILLATORS, IMPLANTABLE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART; HOSPITALIZATION; HUMANS; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK FACTORS; TACHYCARDIA, VENTRICULAR; THALLIUM RADIOISOTOPES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FIBRILLATION;

EID: 0033938062     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000261     Document Type: Article

References (40)

1. 1. Silverman KJ, Becker LC, Bulkley BH, et al. Value of early thallium-201 scintigraphy for predicting mortality in patients with acute myocardial infarction. Circulation 1980; 61: 996-1003.
2. 2. Ong L, Green S, Reiser P, Morrison J. Early prediction of mortality in patients with acute myocardial infarction: a prospective study of clinical and radionuclide risk factors. Am J Cardiol 1986; 57: 33-38.
3. 3. Hakki AH, Nestico P, Heo J, Unwala A, Iskandrian A. Relative prognostic value of rest thallium-201 imaging, radionuclide ventriculography and 24-hour ambulatory electrocardiographic monitoring after acute myocardial infarction. J Am Coll Cardiol 1987; 10: 25-32.
4. 4. Cerqueira MD, Maynard C, Ritchie JL, Davis KB, Kennedy JW. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction Trials. J Am Coll Cardiol 1992; 20: 1452-1459.
5. 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995; 92: 334-341.
6. 6. Gradel C, Jain D, Batsford W, Finkel J, Wackers FJT, Zaret BL. Relationship of scar and ischemia to the results of programmed electrophysiological stimulation in patients with coronary artery disease. J Nucl Cardiol 1997; 4: 379-386.
7. 7. De Sutter J, Tavernier R, Van de Wiele C, et al. QT dispersion is not related to infarct size or inducibility in patients with coronary artery disease and life-threatening ventricular arrhythmias. Heart 1999; 81: 533-538.
8. 8. Gioia G, Bagheri B, Gottlieb CD, et al. Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter defibrillators using SPECT perfusion imaging. Circulation 1997; 95: 390-394.
9. 9. Jordaens L, Hollanders G, De Schrijver A, Simons M, De Backer G, Clement DL. Incidence and prognostic significance of asymptomatic ischaemia in patients with sustained ventricular arrhythmias. Eur Heart J 1988; 9 Suppl N: 128-135.
10. 10. De Sutter J, Van de Wiele C, Gheeraert P, el al. The Selvester 32-point QRS score for evaluation of myocardial infarct size after primary coronary angioplasty. Am J Cardiol 1999; 83: 14-16.
11. 11. Chiba H, Kusuoka H, Ohno J, Nishimura T. Glucose-loading thallium-201 myocardial SPECT. J Nucl Med 1997; 38: 573-577.
12. 12. De Bakker JM, Van Capelle FJ, Janse MJ, et al. Macroreentry in the infarcted human heart: the mechanism of ventricular tachycardias with a "focal" activation pattern. J Am Coll Cardiol 1991; 18: 1005-1014.
13. 13. Downar E, Saito J, Doig JC, et al. Endocardial mapping of ventricular tachycardia in Ihe inlacl human ventricle. III. Evidence of multi-use reentry with spontaneous and induced block in portions of reentrant path complex. J Am Coll Cardiol 1995; 25: 1591-1600.
14. 14. Wellens HJ, Brugada P, Farre J. Ventricular arrhythmias: mechanisms and actions of antiarrhythmic drugs. Am Heart J 1984; 107: 1053-1057.
15. 15. Wit AL, Allessie MA, Bonke FI, Lammers W, Smeets J, Fenoglio JJ Jr. Electrophysiological mapping to determine the mechanism of experimental ventricular tachycardia initiated by premature impulses: experimental approach and initial results demonstrating reentrant excitation. Am J Cardiol 1982; 49: 166-185.
16. 16. Fenoglio JJ, Pham TD, Harken AH, Horowitz LN, Josephson ME, Wit AL. Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates. Circulation 1983; 68: 518-533.
17. 17. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radio frequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993; 88: 1647-1670.
18. 18. Martinez-Rubio A, Schwammenthal Y, Scwhammental E, et al. Patients with valvulvar heart disease presenting with sustained ventricular tachyarrhythmias or syncope. Circulation 1997; 96: 500-508.
19. 19. Gillis AM, Sheldon RS, Wyse G, et al. Long-term reproducibility of ventricular tachycardia induction in patients with implantable cardioverter/defibrillators. Serial noninvasive studies. Circulation 1995; 91: 2605-2613.
20. 20. Duff HJ, Martin JM, Rahmberg M. Time-dependent change in electrophysiological milieu after myocardial infarction in conscious dogs. Circulation 1988; 77: 209-220.
21. 21. Friedman PL, Fenoglio JJ, Wit AL. Time course for reversal of electrophysiological and ultrastructural abnormalities in subendocardial Purkinje fibers surviving extensive myocardial infarction in dogs. Circ Res 1975; 36: 127-144.
22. 22. Arnsdorf MF. Cardiac excitability, the electrophysiologic matrix and electrically induced ventricular arrhythmias: order and reproducibility in seeming electrophysiologic chaos. J Am Coll Cardiol 1991; 17: 139-142.
23. 23. Vanoli E, de Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden cardiac death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68: 1471-1481.
24. 24. Calkins H, Maughan WL, Weisman HF, Sugiura S, Sagawa K, Levine JH. Effect of acute volume load on refractoriness and arrhythmia development in isolated chronically infarcted canine hearts. Circulation 1989; 79: 687-697.
25. 25. Stacy GP Jr, Jobe RL, Taylor LK, Hansen DE. Stretch-induced depolarizations as a trigger of arrhythmias in isolated canine left ventricles. Am J Physiol 1992; 263: H613-H621.
26. 26. Fahy GJ, Sgarbossa EB, Tchou PJ, Pinski SL. Hospital readmission in patients treated with tiered-therapy implantable defibrillators. Circulation 1996; 94: 1350-1356.
27. 27. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol 1996; 27: 67-75.
28. 28. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation 1995; 92: 3264-3272.
29. 29. Narasimhan C, Dhala A, Axtell K, et al. Comparison of outcome of implantable cardioverter defibrillator implantation in patients with severe versus moderately severe left ventricular dysfunction secondary to atherosclerotic coronary artery disease. Am J Cardiol 1997; 80: 1305-1308.
30. 30. Levine JH, Mellits ED, Baumgardner RA, et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation 1991; 84: 558-566.
31. 31. Iskandrian AS, Kegel JG, Tecce MA, Wasserleben V, Cave V, Heo J. Simultaneous assessment of left ventricular perfusion and function with technetium-99m sestamibi after coronary artery bypass grafting. Am Heart J 1993; 126: 1199-1203.
32. 32. Mehta D, Curwin J, Gomes JA, Fuster V. Sudden death in coronary artery disease. Acute ischemia versus myocardial substrate. Circulation 1997; 96: 3215-3223.
33. 33. Gomes JA, Alexopoulous D, Winters SL, Deshmukh P, Fuster V, Suh K. The role of silent ischemia, the arrhythmic substrate and the short-long sequence in the genesis of sudden death. J Am Coll Cardiol 1989; 14: 1618-1625.
34. 34. Leclercq JF, Leenhardt A, Coumel P, Slama R. Efficacy of β-blocking agents in reducing the number of shocks in patients implanted with first-generation automatic defibrillator. Eur Heart J 1992; 13: 1180-1184.
35. 35. O'Rourke RA. Role of myocardial revascularization in sudden cardiac death. Circulation 1992; 85 Suppl I: I112-I117.
36. 36. Autschbach R, Falk V, Gonska BD, Dalichau H. The effect of coronary artery bypass graft surgery for the prevention of sudden cardiac death: recurrent episodes after ICD implantation and review of litterature. PACE 1994; 17 Part II: 552-558.
37. 37. Daoud GE, Niebauer M, Kou WH, et al. Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death. Am Heart J 1995; 130: 277-280.
38. 38. Lessmeier TJ, Lehmann MH, Steinman RT, et al. Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. Am Heart J 1994; 128: 211-215.
39. 39. Rickers C, Buchert R, Lubeck M, Nienaber CA. Pseudoinfarct after placing an epicardial ICD patch electrode: differentiation with SPECT and PET technique. Cardiology 1996; 85: 198-203.
40. 40. Gerber B, Fenelon G, Brugada P, et al. Myocardial perfusion and metabolism in coronary patients with life-threatening ventricular arrhythmias [abstract]. Circulation 1996; 94 Suppl I: I-543.